We are pleased to announce that Ms. Susannah Rose will be doing Ethics Grand Rounds at the Albany Medical College on February 18, 2010 at 12 noon in Huyck Auditorium. Everyone is cordially invited to attend.

Title

�Conflicts of Interest in Academic Medicine�
 
Presenter  

Ms. Susannah Rose, M.S. Bioethics; PhD Candidate, Bioethics and Policy, Harvard University
 
Summary

In this presentation, Ms. Rose will discuss the results of one of her recent publications on conflicts of interest. This study finds that authors of oncology clinical trials who perform key roles in the conception and design, analysis, and interpretation, or reporting of oncology clinical trials are more likely than authors who do not perform such roles to have financial ties to industry. In addition, she will highlight important ethical and policy implications of this study in the context of other studies on conflicts of interest in medicine.
 
Bio

Ms. Susannah Rose graduated from Furman University in 1996 with a BA in Philosophy and Psychology. In 1998, she graduated with an MS in Social Work from Columbia University, and she received an MS in Bioethics from Albany Medical College/Union College in 2006. She is currently a Ph.D. candidate in the ethics concentration of Harvard�s Health Policy Program, a predoctoral fellow at the Center for Outcomes and Policy Research at the Dana-Farber Cancer Institute, and a member of the Ethics Committee at Brigham and Women�s Hospital in Boston. She was a recipient of a predoctoral traineeship from the National Institute of Mental Health from 2006-2008, and she was a graduate fellow at Harvard�s Safra Center of Ethics. Prior to her graduate work at Harvard, Susannah was a clinical social worker and researcher at Memorial Sloan-Kettering Cancer Center in New York City. Susannah has published and presented on many topics related to psychosocial oncology, to bioethics and to health policy. Most recently, Susannah completed a study of the relationship between oncology clinical trial investigators' roles and financial ties to the pharmaceutical industry. She is currently investigating health policy topics related to patient advocacy groups, and she is writing a theoretical paper defining the use of preferences related to the Institute of Medicine�s definition of health care disparities.